Jolanda van Hal Industry news Industry news Category news Reports Key trends Multimedia Multimedia Journal Events Suppliers Suppliers Home Industry news Industry news Category news Reports Key trends Multimedia Multimedia Events Suppliers Suppliers November in review: GLP-1 breakthroughs, UPFs under fire, Novonesis advances healthy longevity Jolanda van Hal Key takeaways GLP-1 science, product pipelines, and consumer acceptance reached a pivotal point in November, reshaping nutrition, pharma, and metabolic health
Even in this study published in Obesity in August and written by Hamlet Gasoyan, PhD, of the Center for Value-Based Care Research at the Cleveland Clinic and the Department of Medicine, at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University School of Medicine, in Cleveland, Ohio, and team, however, researchers have reason to be hopeful
Diabetes may be regulated with medication, and it can be potentially dangerous to start a diet that claims to impact insulin levels without medical supervision, she says
This creates a clinical rationale for considering protein supplementation as part of a comprehensive nutritional strategy during semaglutide treatment
16 and Tables 16
The GLP-1 component slows gastric emptying and signals satiety to the brain